SCHEMBL29966743

SCHEMBL29966743

CC(C(=O)N1OCC[C@H]1c1ccc(F)cc1)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.34
ALDH1A1 P00352 2/20 0.34
CCR1 P32246 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
DPP4 P27487 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
TACR1 P25103 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33
CACNA1H O95180 2/20 0.33
RIPK1 Q13546 1/20 0.33
CACNA1C Q13936 1/20 0.33
NR3C2 P08235 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18921274 1.00 TRPA1 (0.34) TRPA1ALDH1A1CCR1CYP1A2CYP3A4
SCHEMBL18921276 1.00 TRPA1 (0.34) TRPA1ALDH1A1CCR1CYP1A2CYP3A4
SCHEMBL18921520 1.00 TRPA1 (0.34) TRPA1ALDH1A1CCR1CYP1A2CYP3A4
SCHEMBL20580157 0.87 ALDH1A1 (0.42) TRPA1ALDH1A1CCR1CYP1A2CYP3A4
SCHEMBL20580221 0.87 ALDH1A1 (0.42) TRPA1ALDH1A1CCR1CYP1A2CYP3A4
SCHEMBL22210916 0.85 USP30 (0.38) CYP3A4DPP4DPP9DPP7RIPK1
SCHEMBL20580693 0.85 USP30 (0.38) CYP3A4DPP4DPP9DPP7RIPK1
SCHEMBL22210917 0.85 USP30 (0.38) CYP3A4DPP4DPP9DPP7RIPK1
SCHEMBL20580735 0.84 RIPK1 (0.34) RIPK1
SCHEMBL22210975 0.84 RIPK1 (0.34) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602809-B Isoxazolidine derived inhibitors of receptor interacting protein kinase 1(RIPK 1) 戴纳立制药公司 2022-09-30 CN disclosed